Showing 6651-6660 of 9246 results for "".
Easing Concerns About Long-Term Treatment
https://practicaldermatology.com/videos/dermatology-hub-neuroimmune-network/program-name/57015/Natasha Mesinkovsa, MD, outlines how she talks to patients about the lifelong nature of biologic treatment for diseases such as atopic dermatitis and prurigo nodularis.3 Years of Real-World Data for an AD Biologic
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/3-years-of-real-world-data-for-an-ad-biologic/50769/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Chief Medical Editor Neal Bhatia, MD, FAAD, discuss Dr. Bhatia’s article “Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-WorlDiagnostic Approach for Prurigo Nodularis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/diagnostic-approach-for-prurigo-nodularis/37137/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, describes his diagnostic algorithm for prurigo nodularis.The Role of Systemic Steroids in Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37139/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, discusses the role of systemic steroids in treating atopic dermatitis.Sequencing Therapies for Long-Term Control of Atopic Dermatitis
https://practicaldermatology.com/videos/dermatology-hub-neuroimmune-network/sequencing-therapies-for-long-term-control-of-atopic-dermatitis/48786/Christopher Bunick, MD, FAAD, talks about the six effective and safe advanced systemic therapies for atopic dermatitis and how to prescribe them for patients as early as possible by understanding the guidelines and the labels.The Significance of Tolerability and Persistent Efficacy in Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-updates-in-atopic-dermatitis/program-name/57285/Lawrence Eichenfield, MD, discusses evolving topical treatment options for pediatric atopic dermatitis, with a focus on tolerability, efficacy, and persistent disease control.Improving Adherence to Topical Regimens
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/improving-adherence-to-topical-regimens/48780/Zoe Diana Draelos, MD, discusses strategies for improving adherence to topical regimens in chronic atopic dermatitis.The Case for Prioritizing Patient Reacquisition
https://practicaldermatology.com/videos/c-suite-chats/the-case-for-prioritizing-patient-reacquisition/56424/Susie Kozlowski, Business Development Manager for Brevium, explains the importance of patient reacquisition for a dermatology practice.The War Zone: Private Practice
https://practicaldermatology.com/podcasts/the-practical-dermatology-podcast/the-war-zone-private-practice/54847/The War Zone: Private PracticePractical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Editorial Board member Collin Blattner, DO, FAAD, discuss strategies for building a successful private practice in the era of private equity, as well as the challenges associated with it.Evaluating Roflumilast for Seborrheic Dermatitis
https://practicaldermatology.com/videos/skin-minute/evaluating-roflumilast-for-seborrheic-dermatitis/54610/Practical Dermatology Editorial Board member Raj Chovatiya, MD, PhD, MSCI, discusses results from the Phase 3 STRATUM trial studying the efficacy of roflumilast for the treatment of seborrheic dermatitis in patients with diverse skin types.